Key Documents

View All Documentation

Orlistat

Name: Orlistat
Brand: SIGMA

≥98% (HPLC), solid, lipase inhibitor

Synonym(s):

(−)-Tetrahydrolipstatin, N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester, Ro-18-0647

Select a Size

Change View

Size/SKU	Availability	Price

About This Item

Empirical Formula (Hill Notation):

C₂₉H₅₃NO₅

CAS Number:

96829-58-2

Molecular Weight:

495.73

UNSPSC Code:

41106300

PubChem Substance ID:

24724564

NACRES:

NA.77

MDL number:

MFCD05662360

Assay:

≥98%

Form:

solid

Pricing and availability is not currently available.

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Product Name

Orlistat, ≥98%, solid

biological source

synthetic (organic)

Quality Segment

200

assay

≥98%

form

solid

color

white

mp

<50 °C

solubility

DMSO: 19 mg/mL

originator

Roche

storage temp.

−20°C

SMILES string

CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O

InChI

1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1

InChI key

AHLBNYSZXLDEJQ-FWEHEUNISA-N

Gene Information

human ... LIPF(8513), PNLIP(5406)

Description

General description

Orlistat acts as a gastric lipase inhibitor that reduces fat absorption.

Application

Orlistat has been used as an inhibitor:

of fatty acid synthase in long-term estrogen-deprived (LTED) variant cell lines
of lipase in screening lipase inhibition by raspberry extract
in in vitro pancreatic lipase activity assay

Biochem/physiol Actions

Orlistat impairs intestinal fat absorption and is effective in weight management. It is regarded as a safe drug for treating obesity. It delays the progression of type 2 diabetes mellitus especially in obese and improves glycemic parameters. Long term usage of orlistat results in improved weight reduction and it may not contribute in colorectal carcinogenesis.

Orlistat, used in obesity research, is a pancreatic lipase inhibitor that acts locally in the gastrointestinal tract to inhibit lipase.

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Other Notes

Solution is not completely clear, small particles may remain floating.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item	U111	SML1938	M1318
Sigma-Aldrich O4139 Orlistat	Sigma-Aldrich U111 (−)-trans-(1S,2S)-U-50488 hydrochloride hydrate	Sigma-Aldrich SML1938 LY450139	Sigma-Aldrich M1318 Milnacipran hydrochloride
description ≥98%, solid	description solid, ≥98% (HPLC)	description ≥98% (HPLC)	description ≥98% (HPLC), solid
assay ≥98%	assay ≥98% (HPLC)	assay ≥98% (HPLC)	assay ≥98% (HPLC)
form solid	form solid	form powder	form solid
Quality Level 200	Quality Level 100	Quality Level 100	Quality Level 100
storage temp. −20°C	storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C
solubility DMSO: 19 mg/mL	solubility H₂O: 13 mg/mL	solubility DMSO: 20 mg/mL, clear	solubility H₂O: 19 mg/mL
color white	color white	color white to beige	color white

Still not finding the right product?

Explore all of our products under Orlistat

Storage Class

11 - Combustible Solids

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable

PPE (personal protective equipment)

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.